BENITEC BIOPHARMA INC (BNTC) Institutional Ownership and Insiders Activity

BENITEC BIOPHARMA INC (BNTC) is widely held by institutional investors, with 87 firms reporting positions valued at approximately $405.17M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Suvretta Capital Management, Llc is the largest disclosed holder, reporting approximately $154.52M in BNTC holdings in its latest filing.